201 related articles for article (PubMed ID: 22632258)
1. Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?
Romeu B; Gonzalez E; Lastre M; Pérez O
J Drug Target; 2012 Jul; 20(6):502-8. PubMed ID: 22632258
[TBL] [Abstract][Full Text] [Related]
2. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
Lawson LB; Norton EB; Clements JD
Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
[TBL] [Abstract][Full Text] [Related]
3. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
4. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
[TBL] [Abstract][Full Text] [Related]
5. Starch microparticles as vaccine adjuvant.
Rydell N; Stertman L; Sjöholm I
Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
[TBL] [Abstract][Full Text] [Related]
6. Translating innate immunity into immunological memory: implications for vaccine development.
Pulendran B; Ahmed R
Cell; 2006 Feb; 124(4):849-63. PubMed ID: 16497593
[TBL] [Abstract][Full Text] [Related]
7. BAFF, stimulatory DNA and IL-15 stimulates IgA(+) memory B cells and provides a novel approach for analysis of memory responses to mucosal vaccines.
Tengvall S; Lundgren A; Quiding-Järbrink M; Svennerholm AM
Vaccine; 2010 Jul; 28(33):5445-50. PubMed ID: 20547203
[TBL] [Abstract][Full Text] [Related]
8. New generation of mucosal adjuvants for the induction of protective immunity.
Yuki Y; Kiyono H
Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
[TBL] [Abstract][Full Text] [Related]
9. Induction and direction of immune responses by vaccine adjuvants.
Schijns VE
Crit Rev Immunol; 2001; 21(1-3):75-85. PubMed ID: 11642615
[TBL] [Abstract][Full Text] [Related]
10. Induction of secretory immunity and memory at mucosal surfaces.
Brandtzaeg P
Vaccine; 2007 Jul; 25(30):5467-84. PubMed ID: 17227687
[TBL] [Abstract][Full Text] [Related]
11. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
12. Current adjuvants and new perspectives in vaccine formulation.
Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
[TBL] [Abstract][Full Text] [Related]
13. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.
Ranasinghe C; Ramshaw IA
Expert Rev Vaccines; 2009 Sep; 8(9):1171-81. PubMed ID: 19722891
[TBL] [Abstract][Full Text] [Related]
15. Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
Ahlers JD; Belyakov IM
Eur J Immunol; 2009 Oct; 39(10):2657-69. PubMed ID: 19609978
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
17. Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations.
Zimmermann S; Lepenies B
Methods Mol Biol; 2015; 1331():11-26. PubMed ID: 26169732
[TBL] [Abstract][Full Text] [Related]
18. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
[TBL] [Abstract][Full Text] [Related]
20. Jump-starting the immune system: prime-boosting comes of age.
Woodland DL
Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
